Subject: Specialty Quantity Limit Epidiolex 2611-H P2023
Policy:
I. PROGRAM DESCRIPTION
The standard limit is designed to allow a quantity sufficient for
the most common uses of the medication. If the member’s plan
allows a quantity limit exception review for the requested
medication, coverage of an additional quantity may be provided
up to the exception limit with prior authorization.
II. COVERED QUANTITIES
|
Medication
|
Standard Limit
|
Exception Limit*
|
FDA-recommended dosing
|
|
Epidiolex 100 mg/mL oral solution
|
800 mL per 30 days
|
1500 mL per 30 days
|
Seizures Associated with Lennox-Gastaut Syndrome or Dravet Syndrome • Initial dose: 2.5 mg/kg twice daily. After one week, increase to a maintenance dose of 5 mg/kg twice daily. Increase in weekly increments of 2.5 mg/kg twice daily. • Maximum dose: 10 mg/kg twice daily.
Seizures Associated with Tuberous Sclerosis Complex • Initial dose: 2.5 mg/kg twice daily. Increase to a maintenance dose of 12.5 mg/kg twice daily. Increase in weekly increments of 2.5 mg/kg twice daily.
Dose adjustment • With a strong inducer of CYP3A4 or CYP2C19: Dose increase of Epidiolex may be considered based on clinical response and tolerability.
|
*Coverage up to the exception limit may be provided with prior authorization via the Specialty Post Limit Quantity Exception Criteria for approval.
Place of Service:
Outpatient
The above policy is based on the following references:
- Epidiolex [package insert]. Palo Alto, CA: Jazz Pharmaceuticals, Inc.; January 2023.
Copyright Aetna Inc. All rights reserved. Pharmacy Clinical Policy Bulletins are developed by Aetna to assist in administering plan benefits and constitute neither offers of coverage nor medical advice. This Clinical Policy Bulletin contains only a partial, general description of plan or program benefits and does not constitute a contract. Aetna does not provide health care services and, therefore, cannot guarantee any results or outcomes. Participating providers are independent contractors in private practice and are neither employees nor agents of Aetna or its affiliates. Treating providers are solely responsible for medical advice and treatment of members. This Clinical Policy Bulletin may be updated and therefore is subject to change.
October 15, 2023